Quantcast
Home > Quotes > VAPO

Vapotherm, Inc. Common Stock (VAPO) Quote & Summary Data

VAPO 
$16.5
*  
0.15
0.9%
Get VAPO Alerts
*Delayed - data as of Feb. 15, 2019  -  Find a broker to begin trading VAPO now
Exchange:NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
25.5
Today's High / Low
$ 16.74 / $ 16.44
Share Volume
31,724
90 Day Avg. Daily Volume
61,966
Previous Close
$ 16.65
52 Week High / Low
$ 22.07 / $ 14.70
Market Cap
276,093,263
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0

Intraday Chart

Shares Traded

Share Volume:
31,724
90 Day Avg. Daily Volume:
61,966

Trading Range

The current last sale of $16.50 is 12.24% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 16.74 $ 22.07
 Low: $ 16.44 $ 14.70

Company Description (as filed with the SEC)

We are a global medical technology company focused on the development and commercialization of our proprietary Hi-VNI Technology products that are used to treat patients of all ages suffering from respiratory distress. Our Hi-VNI Technology delivers noninvasive ventilatory support by providing heated, humidified and oxygenated air at a high velocity to patients through a comfortable small-bore nasal interface. Our Precision Flow systems, which use Hi-VNI Technology, are clinically validated alternatives to, and address many limitations of, the current standard of care for the treatment of respiratory distress in a hospital setting. As of September 30, 2018, more than 1.5 million patients have been treated with our Precision Flow systems, and we have a global installed base of over 13,000 capital units.  ... More ...  


Risk Grade

Where does VAPO fit in the risk graph?


Risk Grade Scale

Consensus Recommendation

Analyst Info